StonvexLoading…
StonvexStonvexStonvexCore line items from FUTU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.36B | $778.19M | $505.04M | $513.70M |
Operating Income | $1.81B | $852.47M | $641.09M | $3.57B |
Net Income | $1.46B | $700.73M | $548.14M | $375.18M |
EPS (Diluted) | $1.29 | $0.63 | $0.49 | $0.33 |
Total Assets | $29.35B | $20.44B | $12.44B | $12.11B |
Total Liabilities | $24.17B | $16.83B | $9.29B | $9.44B |
Cash & Equivalents | $1.34B | $1.50B | $632.13M | $644.61M |
Free Cash Flow OCF − CapEx | $5.23B | $3.97B | $-821.31M | $433.81M |
Shares Outstanding | 1.13B | 1.12B | 1.12B | 1.15B |